Investigation of Genetic Mutations in High-risk and Low-risk Basal Cell Carcinoma in a Non-Caucasian Population by Whole Exome Sequencingopen access
- Authors
- Kim, Hyun Jee; Lee, Minho; Lee, Young Bok; Yu, Dong Soo
- Issue Date
- Jun-2021
- Publisher
- ACTA DERMATO-VENEREOLOGICA
- Keywords
- basal cell carcinoma; whole exome sequencing; skin cancer; genetics; histopathology; mutation
- Citation
- ACTA DERMATO-VENEREOLOGICA, v.101, no.5
- Indexed
- SCIE
SCOPUS
- Journal Title
- ACTA DERMATO-VENEREOLOGICA
- Volume
- 101
- Number
- 5
- URI
- https://scholarworks.dongguk.edu/handle/sw.dongguk/4913
- DOI
- 10.2340/00015555-3820
- ISSN
- 0001-5555
1651-2057
- Abstract
- This study analysed genomic mutations in basal cell carcinoma using whole exome sequencing of DNA specimens obtained from 20 Korean patients. Histological evaluation determined that 15 (75%) were low-risk basal cell carcinomas, and 5 (25%) were high-risk basal cell carcinomas. Seventy-five percent of the basal cell carcinomas harboured somatic mutations in hedge-hog pathway genes (PTCH1, 40% and SMO, 50%) and 45% harboured mutations in TP53. LRP1B was the most frequently mutated gene in high-risk basal cell carcinomas, SMO was the most frequently mutated gene in low-risk basal cell carcinomas. Specifically, LRP1B, ROS1, PTCH1, KMT2C, NSD1 and ARID1A mutations were more frequent in high-risk basal cell carcinomas than in low-risk basal cell carcinomas. However, copy number gains of the ROS1 gene were observed only in low-risk basal cell carcinomas. Other basal cell carcinoma related genes found in this study include: KDR, KMT2D, FAT1, FAT4, GRIN2A, ERBB4, NOTCH2, PDE4DIP, TET1, ZFHX3 and PREX2. These results provide insight into basal cell carcinoma in non-Caucasians.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - College of Life Science and Biotechnology > Department of Life Science > 1. Journal Articles

Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.